Protalix Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.71

+0.03 (+1.12%)

As of Oct 3, 2:17 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +1,051.7% upside

Low Target $17.92

Average Target $31.21

High Target $31.70

Current Price $2.71

Current
$2.71

Target
$31.21

$17.92 $31.21 avg $31.70

Scenario Analysis

Bear Case

$17.92

561.3%

Low target

Base Case

$31.21

+1,051.7%

Avg target

Bull Case

$31.70

+1,069.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.19

-15.0% from high

52-Week Low

$1.60

+69.4% from low

Target vs 52W High

$31.21

+878.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-52.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+150.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-21.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.8%